At last, six studies [23], [30], [31], [32], [33], [34] on MDM2 SNP309 genotypes and ovarian cancer risk were identified, including a total of 1534 ovarian cancer cases and 2211 controls. This evidence concerns the gene MDM2 and ovarian carcinoma.